Certified by Founder Lodge
SANTÉ
United States - Austin, Texas
INVESTOR
1 Disclosed Funding Rounds $6,000,000
125 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Santé invests at the leading edge of innovation in Healthcare and Technology. We manage over a half-billion dollars of capital invested in two separate strategies.
Santé Ventures invests
| Company | Date | Round | Raised |
|---|---|---|---|
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Wave |
March, 08 ,2023 | Seed | $6,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Wave |
March, 08 ,2023 | Seed | $6,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Graici |
February, 04 ,2026 | Series A | $7,500,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Graici |
February, 04 ,2026 | Series A | $7,500,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
beHuman Corp. |
February, 05 ,2026 | Seed | $4,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Graici |
February, 04 ,2026 | Series A | $7,500,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Graici |
February, 04 ,2026 | Series A | $7,500,000 |
beHuman Corp. |
February, 05 ,2026 | Seed | $4,000,000 |
Axon Therapies Inc.
Surgical Safety Technologies Inc.
Solu Therapeutics
Apreo Health
Reprieve Cardiovascular
Endogenex
Wave
ABK Biomedical Inc.
OutcomesAI
Clairity, Inc.
AI Proteins
Graici
beHuman Corp.
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
inKind | $450,000,000 | (Feb 19, 2026)
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Zero Homes | $16,800,000 | (Feb 19, 2026)